| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |